IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,291,785 | +504.1% | 2,210,985 | +566.8% | 0.24% | +505.1% |
Q2 2023 | $3,524,738 | -22.3% | 331,584 | -23.1% | 0.04% | -38.1% |
Q1 2023 | $4,536,929 | +50.3% | 431,267 | +77.1% | 0.06% | +43.2% |
Q4 2022 | $3,017,919 | +0.5% | 243,577 | -16.0% | 0.04% | -4.3% |
Q3 2022 | $3,004,000 | -87.7% | 290,002 | -86.3% | 0.05% | -86.5% |
Q2 2022 | $24,344,000 | +3.1% | 2,109,530 | +12.4% | 0.34% | +22.1% |
Q1 2022 | $23,609,000 | +17.3% | 1,876,727 | +9.1% | 0.28% | +26.7% |
Q4 2021 | $20,135,000 | +0.3% | 1,720,956 | +11.9% | 0.22% | -2.6% |
Q3 2021 | $20,077,000 | +0.9% | 1,537,262 | -0.7% | 0.23% | +10.7% |
Q2 2021 | $19,900,000 | +308.7% | 1,547,452 | +255.3% | 0.20% | +327.1% |
Q1 2021 | $4,869,000 | +1.3% | 435,529 | +3.1% | 0.05% | 0.0% |
Q4 2020 | $4,806,000 | +1075.1% | 422,348 | +828.4% | 0.05% | +1100.0% |
Q3 2020 | $409,000 | – | 45,491 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |